The global Pneumonia Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pneumonia Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type Pneumococcal Conjugate Vaccine (PCV13) Pneumococcal Polysaccharide Vaccine (PPSV23) Segment by Application Pneumonia Meningitis Sepsis The Pneumonia Vaccine market is analysed and market size information is provided by regions (countries). Segment by Application, the Pneumonia Vaccine market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions. By Company Pfizer Inc. Glaxosmithkline Plc. Merck & Co., Inc. Sanofi Pasteur Serum Institute of India Pvt. Ltd. Johnson & Johnson Astellas Pharma Inc. Astrazeneca Plc. CSL Limited Emergent Biosolutions
1 Pneumonia Vaccine Market Overview 1.1 Pneumonia Vaccine Product Scope 1.2 Pneumonia Vaccine Segment by Type 1.2.1 Global Pneumonia Vaccine Sales by Type (2016 & 2021 & 2027) 1.2.2 Pneumococcal Conjugate Vaccine (PCV13) 1.2.3 Pneumococcal Polysaccharide Vaccine (PPSV23) 1.3 Pneumonia Vaccine Segment by Application 1.3.1 Global Pneumonia Vaccine S